SOX9 siRNA Loaded Lipid Nanoparticles Actively Targeted: Formulation, Delivery, and Antitumor Effect on Colorectal Cancer In Vitro and In Vi vo
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.5c00272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Zhen Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China. Hauptthemen laut MEDLINE: RNA, Small Interfering, Colorectal Neoplasms, Nanoparticles, SOX9 Transcription Factor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 76 Literaturangaben.
Abstract (Originalsprache)
Small interfering RNA (siRNA)-based therapy, which silences disease-associated genes, has emerged as a potential therapeutic strategy for various disorders, including cancer. Lipid nanoparticles (LNPs) have become a leading platform for efficient siRNA delivery. SOX9, a family member of SRY-related high-mobility-group box (SOX) transcription factors, plays an important role in the pathogenesis and progression of colorectal cancer (CRC). Here, we developed cRGDfK peptide-modificed LNPs (R-LNPs) composed of DLin-MC3-DMA, DMG-PEG, DSPC, DSPE-PEG-cRGDfK, and cholesterol for the targeted delivery of SOX9 siRNA (siSOX9) in CRC treatment. The formulation, delivery, and antitumor effect on CRC in vitro and in vivo were explored. The optimized R-LNPs exhibited favorable physicochemical properties including a uniform particle size (159.6 ± 0.93 nm), low polydispersity index (PDI = 0.207 ± 0.016), near-neutral zeta potential (2.74 ± 0.35 mV), and high encapsulated efficiency (90.71 ± 1.63%). Additionally, R-LNPs demonstrated sustained and controlled in vitro release and good serum stability. The prepared R-LNPs were efficiently uptaken by HCT-116 via clathrin, lipid rafts, and caveolae dependent endocytosis and macropinocytosis. Subsequently, R-LNPs were colocalized with lysosomes before escaping into the cytoplasm, ensuring effective siRNA release. In vivo distribution studies confirmed tumor-specific accumulation for R-LNPs in HCT-116 xenograft models. Functionally, R-LNPs loading siSOX9 inhibited the proliferation, migration, and invasion of HCT-116 cells and Caco-2 cells (P < 0.05 or 0.01) and inhibited tumor growth and proliferation in tumor-bearing mice (P < 0.05 or 0.01). The antitumor effects were attributed to the silence of SOX9, which subsequently downregulated key oncogenic mediators, including β-catenin, cyclin D1, and c-Myc (P < 0.05 or 0.01). Furthermore, R-LNPs demonstrated favorable safety in in vivo application. In conclusion, our cRGDfK-modified LNPs loading siSOX9 represent a promising targeted therapeutic strategy for CRC, offering both efficacy and biocompatibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China.
- Department of Gastrointestinal Surgery, the People's Hospital of Jimo, Qingdao 266200, China.
- Department of Physiology, School of Basic Medicine, Qingdao University, Qingdao 266073, China.
- Department of Pharmacy, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, China.
ORCID-Profile: Yanling Gong
Zitieren
APA
Zhang, Z., Wang, H., Zhang, Z., Zhang, Y., Sun, H., Chen, X., Gu, J., & Gong, Y. (2025). SOX9 siRNA Loaded Lipid Nanoparticles Actively Targeted: Formulation, Delivery, and Antitumor Effect on Colorectal Cancer In Vitro and In Vi vo. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00272
Vancouver
Zhang Z, Wang H, Zhang Z, Zhang Y, Sun H, Chen X, et al. SOX9 siRNA Loaded Lipid Nanoparticles Actively Targeted: Formulation, Delivery, and Antitumor Effect on Colorectal Cancer In Vitro and In Vi vo. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00272
BibTeX
@article{Zhang2025,
author = {Zhang, Zhen and Wang, Hongbo and Zhang, Zhijun and Zhang, Yaoyao and Sun, Huajing and Chen, Xi and Gu, Jiayu and Gong, Yanling},
title = {SOX9 siRNA Loaded Lipid Nanoparticles Actively Targeted: Formulation, Delivery, and Antitumor Effect on Colorectal Cancer In Vitro and In Vi vo},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.5c00272}
}
EUVIMED